MethylPREDNISolone Dose Pack Alternatives Compared
| MethylPREDNISolone Dose Pack | Dupixent | Upadacitinib |
|
|---|
| MethylPREDNISolone Dose Pack (methylprednisolone) | Dupixent (dupilumab) | Upadacitinib |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Allergic Rhinitis, Asthma, Adrenogenital Syndrome, Asthma - acute, Asthma - Maintenance, Atopic Dermatitis, Dermatologic Lesion, Gout - Acute, Immunosuppression, Inflammatory... View more |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Related suggestions Atopic Dermatitis
Popular comparisons
|
|||||||||||||||
| More about MethylPREDNISolone Dose Pack (methylprednisolone) | More about Dupixent (dupilumab) | More about Upadacitinib | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
MethylPREDNISolone Dose Pack has an average rating of 8.3 out of 10 from a total of 50 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 11% reported a negative effect. |
Dupixent has an average rating of 7.1 out of 10 from a total of 466 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 22% reported a negative effect. |
Upadacitinib has an average rating of 6.8 out of 10 from a total of 200 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: MethylPREDNISolone Dose Pack side effects in more detail. |
See also: Dupixent side effects in more detail. |
See also: upadacitinib side effects in more detail. |
||||||||||||||||
| Generic Availability | ||||||||||||||||||
| Lower cost generic approved |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all MethylPREDNISolone Dose Pack prices |
View all Dupixent prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other methylprednisolone brands include: Depo-Medrol, Medrol, Medrol Dosepak, Solu-Medrol |
N/A |
Rinvoq, Rinvoq LQ | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
3.5 hours |
N/A |
14 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
Excluding First Trimester
Category D
Positive evidence of risk
First Trimester See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 592 drugs are known to interact with MethylPREDNISolone Dose Pack:
|
A total of 76 drugs are known to interact with Dupixent:
|
A total of 580 drugs are known to interact with upadacitinib:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
March 28, 2017 |
August 16, 2019 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.